Home / Team / KAIST Team


Dong Soo Yang – PhD Student
Email: dosoyang@kaist.ac.kr

Dongsoo Yang is currently a Ph.D. student in Korea Advanced Institute of Science and Technology (KAIST), South Korea under the supervision of Prof. Sang Yup Lee. He earned his B.S. degree in the same institution, KAIST, with chemical and biomolecular engineering major and chemistry minor. His research field lies in metabolic engineering, systems biology and synthetic biology. His current studies are focused on developing various metabolic engineering and synthetic biology tools including small regulatory RNAs for heterologous production of medicinal secondary metabolites in Escherichia coli. In the IIMENA team, he will be taking part in developing robust bacterial hosts including E. coli for efficient heterologous production of novel antibiotics.

Kyeong Rok Choi – PhD Student
Email: chkr1018@kaist.ac.kr

Kyeong Rok Choi is a Ph.D. student in Metabolic and Biomolecular Engineering National Laboratory (MBEL) at Korea Advanced Institute of Science and Technology (KAIST). He develops synthetic biology tools for efficient bacterial strain development. Applying the new tools developed, he engineers microorganisms producing value-added chemicals from renewable carbon sources, combining disciplines of metabolic engineering and synthetic biology. Previously, he metabolically engineered bacteria for the production of valuable chemicals and developed biological method for the production of metallic nanoparticles (e.g. quantum dots), as a researcher in MBEL. He was actively involved in developing synthetic single-copy genetic circuit in Collins lab at Boston University (currently at MIT) and developing drug combination therapy for ovarian cancer treatment in Hasan lab at Wellman Center for Photomedicine at Massachusetts General Hospital, as an intern. Elucidation of cell aggregation mechanism in a photoautotrophic bacterium is another research theme he devoted to. He double majored in chemical & biomolecular engineering and biological sciences at KAIST. In the IIMENA team, he will be takeing part of developing of bacterial genome engineering tools, DNA manipulation tools for BCGs and bacterial strains (including E. coli) producing new antibiotics